DDrare: Database of Drug Development for Rare Diseases

Hydrochlorothiazide/amiloride (DrugBank: Amiloride, Hydrochlorothiazide)

4 diseases

ID	Disease name (Link within this page)	Number of trials
13	Multiple sclerosis/Neuromyelitis optica	0
67	Polycystic kidney disease	0
225	Congenital nephrogenic diabetes insipidus	1
235	Hypoparathyroidism	0

13. Multiple sclerosis/Neuromyelitis optica [ 3,050 clinical trials, 2,147 drugs, (DrugBank: 348 drugs), 244 drug target genes, 228 drug target pathways]

Searched query = "Multiple sclerosis/Neuromyelitis optica", "Multiple sclerosis", "Neuromyelitis optica", "MS", "NMOSD", "Devic disease", "Balo concentric sclerosis", "Baló concentric sclerosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.

0 / 3,050 trial found

67. Polycystic kidney disease [ 186 clinical trials, 196 drugs, (DrugBank: 47 drugs), 35 drug target genes, 146 drug target pathways]

Searched query = "Polycystic kidney disease", "PKD", "PCKD", "Polycystic kidney", "ADPKD", "ARPKD"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.

0 / 186 trial found

225. Congenital nephrogenic diabetes insipidus [ 12 clinical trials, 45 drugs, (DrugBank: 17 drugs), 30 drug target genes, 63 drug target pathways]

Searched query = "Congenital nephrogenic diabetes insipidus", "Hereditary nephrogenic diabetes insipidus", "Nephrogenic diabetes insipidus"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 12 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00478335 (ClinicalTrials.gov)	May 2007	23/5/2007	Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus	Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus	Nephrogenic Diabetes Insipidus	Drug: sildenafil;Drug: calcitonin;Drug: hydrochlorothiazide/amiloride;Drug: indomethacin;Drug: Placebo for sildenafil;Drug: placebo for calcitonin	University of Colorado, Denver	University of Aarhus	Completed	5 Years	25 Years	Male	4	N/A	United States;Denmark

235. Hypoparathyroidism [ 67 clinical trials, 112 drugs, (DrugBank: 24 drugs), 4 drug target genes, 5 drug target pathways]

Searched query = "Hypoparathyroidism", "Accessory thyroid hypergasia disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.

0 / 67 trial found